After an expert panel review of Gilead’s Remdesivir, no evidence was found that it was effective in treating COVID-19. In October, the U.S. Food and Drug Administration (FDA) granted the drug approval for usage in hospitals, and after rescinding the approval, Gilead is arguing the World Health Organization’s (WHO) findings.  

Read more here.  

More on: